| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aldeyra Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 3,619 | 10 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics, Inc. | 10 Jun 2025 | 3 | $0 | 4 | Director | 12 Jun 2025, 16:21 |
| ALDX | Aldeyra Therapeutics, Inc. | 04 Jun 2024 | 3 | $0 | 4 | Director | 06 Jun 2024, 16:06 |
| ALDX | Aldeyra Therapeutics, Inc. | 07 Sep 2023 | 2 | +$3,001 | 4 | Director | 11 Sep 2023, 17:31 |
| ALDX | Aldeyra Therapeutics, Inc. | 30 Jun 2023 | 3 | $0 | 4 | Director | 05 Jul 2023, 17:43 |
| ALDX | Aldeyra Therapeutics, Inc. | 07 Jun 2022 | 3 | $0 | 4 | Director | 09 Jun 2022, 17:06 |
| ALDX | Aldeyra Therapeutics, Inc. | 08 Jun 2021 | 3 | $0 | 4 | Director | 10 Jun 2021, 17:46 |